Hospira Bulks Up Pfizer’s Established Products Unit, But Won’t Speed A Split

Pfizer’s acquisition of sterile injectables specialist Hospira will strengthen its Global Established Pharmaceutical business, but management said it will need time to determine whether or not to break up the business.